FindTrial
Sign In

TK-641 Phase 3 Study

TK-641 Phase 3 Study

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080221351
Enrollment
Unknown
Registered
2011-01-14
Start date
2011-01-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer pain

Interventions

investigational material(s) Generic name etc : TK-641 INN of investigational material : Oxycodone Hydrochloride Hydrate Therapeutic category code : 811 Opium alkaloids preparations Dosage and Administ

Sponsors

TEIKOKU SEIYAKU CO., LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Cancer patients who can be hospitalized for clinical trial 2) Patients who are 20-74 years old at the time of informed consent 3) Patients who have been received cancer pain therapy with opioid etc.

Exclusion criteria

Exclusion criteria: 1) Patients who have any complications or history of cardiac conduction disturbance 2) Patients who have any complications or history of abnormality of respiratory function 3) Patients with any organic encephalopathies etc.

Design outcomes

Primary

MeasureTime frame
Efficacy and Safety—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026